adverse effect on the Group's net assets, financial condition and results of operations. There can be no assurance that the Group will not, from time to time, be alleged to have underpaid its taxes and
reversal of deferred tax assets. Financial Ratios Q2 2020 Q2 2019 Gross profit margin 18.9% 20.7% Net profit margin 8.5% 14.3% Debt to Equity ratio 0.18 0.10 Earnings per share 0.26 0.57 ROA 6.1% 12.2% ROE
cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
/…… - 3 - - More preventive expenses for ASF - Increase more distribution channels and sales promotions - Loss on change in fair value less cost to sale of biological assets Financial Position Assets As of
for rent and Baht 5.4 Million from gain on change in fair value less cost of sale of biological assets. Financial Cost Financial cost in Q2/2020 was Baht 8.1 Million had decreased by Baht 0.4 Million or
future obligation • THB 0.76 million of loss from disposition of investment in associates • THB 1.83 million of loss from write-off of assets FINANCIAL POSITION 5 | MANAGEMENT DISCUSSION AND ANALYSIS 2019
loan and the Hua-Pha-Way Kiln 7 loan continue to be repaid. Shareholder equity reduced with the lower net result and reduced current assets. Financial Position Summary as of 31 December 2019 compared to
Rate • Loss on Exchange Rate was recorded at Baht 93 million in Q1’2018, primarily attributable to a loss and/or an unrealized loss on exchange rate from trade payable and other assets. FINANCIAL
on Exchange Rate at Baht 0.2 million in 6M’2018 and Baht 94 million in Q2’2018, primarily attributable to an unrealized gain on exchange rate from trade payable and other assets. FINANCIAL PERFORMANCE
dollar and Loss on Exchange Rate at Baht 15 million in Q4’2019 due to an unrealized loss on exchange rate from other assets. FINANCIAL PERFORMANCE 7 2018 2019 change Q4’18 Q3’19 Q4’19 change change Btmn